Medera’s SPAC Merger Marks Rare Biotech Move
Medera aims for Nasdaq listing via SPAC to boost gene therapies, spotlighting rare biotech SPACs in 2024.
- Latest
- Trending
Medera aims for Nasdaq listing via SPAC to boost gene therapies, spotlighting rare biotech SPACs in 2024.
The US imposes new tech export controls, aligning with partners, impacting quantum computing and semiconductor sectors.
Critical Metals initiates 14-hole drilling in Greenland's Tanbreez, the largest rare earth deposit worldwide.
ArsenalBio raises $325M to advance solid tumor CAR-T therapies. Focus on kidney, prostate cancer with innovative genomic technology.
Mitigram and Fides partner to enhance global trade finance through streamlined bank communication and digital connectivity.
Discover investment opportunities in smaller AI stocks often overlooked by investors focused on giants like Nvidia.
Ethereum on-chain activity hits record highs as fees drop 99%. This trend boosts user engagement and decentralized finance.
Notre Dame uses microgravity to enhance early cancer detection via blood tests, potentially transforming diagnostic methods.
Teacher Next Door unveils a fast, user-friendly site to help public servants access up to $15,000 in home buying assistance.
New Fortress Energy authorized to export LNG to non-FTA countries, boosting energy trade and growth in Latin America.
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.